|
MANCHESTER, England, March 8, 2017 /PRNewswire/ --
External Validation Studies Show Sensitivity of Greater Than 99% and Specificity of 100% for Hepatitis C Assay Designed for Decentralised Use in Resource Limited Settings
genedrive plc, the near patient molecular diagnostics... |
